Faster Approval Does Not Mean Faster Reimbursement
Several Factors Can Prolong HTA Decision Time
Executive Summary
Securing accelerated assessment for a drug in any regulatory jurisdiction is a major boost for drug companies, but it does not necessarily translate into an earlier reimbursement decision.